Effectiveness and safety of abatacept for the treatment of patients with primary Sjögren's syndrome.

Sjögren's syndrome is an autoimmune disease characterized by inflammation of the exocrine glands. The disease can be primary or secondary (if it is associated with another autoimmune disease). In Barring symptom management, there is no established treatment. To evaluate the effectiveness and safety of abatacept as a treatment of primary Sjögren's syndrome over the course of 24 months. Eleven patients with primary Sjögren's syndrome from the Rheumatology Department of Universidade Santo Amaro, Sao Paulo, Brazil were enrolled for a prospective observational study. Eligible participants were diagnosed according to the 2002 American-European consensus criteria and had a score greater than 3 on the EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI). Participants received intravenous abatacept for 24 months at a weight-adjusted dose of 500 mg for patients weighing < 60 kg and 750 mg for those weighing > 60 kg. The outcomes were ESSDAI activity index, non-stimulated salivary flow rate, ocular dryness (Schirmer test, tear film break-up time, and ocular staining score), SF-36 questionnaire, and Fatigue domain of the FACIT (Functional Assessment of Chronic Illness Therapy) index. There was a statistically significant reduction in ESSDAI index and improvement of salivary flow. One subscale of the SF-36 index-emotional role functioning-showed improvement. There was no change in ocular parameters or in the FACIT index. In this sample of 11 patients with primary Sjögren's syndrome, abatacept therapy improved xerostomia and systemic disease activity.Key Points• Abatacept is safe and effective for the treatment of primary Sjögren's syndrome.• Abatacept can improve salivary flow and ESSDAI index in this patient population.

Fórum Vascular: inteligência coletiva na resolução de casos clínicos vasculares / Vascular Forum: collective intelligence in the resolution of vascular clinical cases

Contexto: A inteligência coletiva tem extrema importância em grupos coletivos de discussão de casos clínicos médicos, auxiliando tanto os profissionais na pronta tomada de decisão como seus pacientes. Objetivos: Avaliar a resolutividade e as características das discussões clínicas realizadas em grupo fechado de mensagens instantâneas e sua aplicabilidade clínica. Métodos: Análise retrospectiva de discussões clínicas e eventos no Fórum Vascular, grupo aberto para especialistas em dispositivos móveis. Resultados: No período de julho de 2015 a julho de 2017, foram discutidos 1.013 assuntos, com 680 membros. Desses assuntos, 26 (2,57%) foram curiosidades, 101 (9,97%) foram dúvidas de diagnóstico, 492 (48,57%) foram dúvidas de tratamento, 205 (20,24%) foram dúvidas gerais e 189 (17,5%) foram relatos de casos. O número médio de interações por evento foi de 16,599 (±1,366). O tempo médio para a primeira resposta foi de 42,14 min (±7,55). Os assuntos discutidos foram 358 casos com miscelânea, 336 casos venosos, 15 casos linfáticos e 304 casos arteriais, totalizando 15.985 respostas. Conclusões: A interação entre especialistas utilizando a tecnologia de troca de mensagens instantâneas mostrou-se capaz de levantar discussões e abordagens rapidamente. A resolutividade, considerada o tempo da primeira resposta correta, também foi alta. O Fórum Vascular evidenciou­se uma ferramenta de grande valia clínica para seus participantes, confirmando a importância da inteligência coletiva na área médica

Background: Collective intelligence is extremely important in collective groups that discuss clinical medical cases, assisting professionals in their decision-making processes, and consequently, helping their patients. Objectives: To evaluate the rate of resolution and characteristics of the clinical discussions carried out in a private instant messaging group and its clinical applicability. Methods: Retrospective analysis of clinical discussions and events on the Vascular Forum, an open group for specialists accessed with mobile devices. Results: From July 2015 to July 2017, 1013 subjects were discussed among 680 members. Twenty-six (2.57%) of these subjects were curiosities, 101 (9.97%) related to diagnostic doubts, 492 (48.57%) to treatment doubts, and 205 (20.24%) to general doubts, while 189 (17.5%) were case reports. The mean number of interactions per event was 16.599 (±1.366). The mean time from posting of a new subject to the first reply was 42.14 (±7.55) min. The subject discussed was miscellaneous in 358 cases, venous in 336 cases, lymphatic in 15 cases, and arterial in 304 cases and the total number of replies was 15985. Conclusions: Interaction between experts using instant messaging technology proved capable of raising subjects for discussion and eliciting management approaches quickly. The rate of resolution, defined as the time taken for the first correct answer to be posted, was also high. The Vascular Forum proved to be a tool of great clinical value for its participants, confirming the importance of collective intelligence in medicine

Vascular Forum: collective intelligence in the resolution of vascular clinical cases.

BACKGROUND: Collective intelligence is extremely important in collective groups that discuss clinical medical cases, assisting professionals in their decision-making processes, and consequently, helping their patients. OBJECTIVES: To evaluate the rate of resolution and characteristics of the clinical discussions carried out in a private instant messaging group and its clinical applicability. METHODS: Retrospective analysis of clinical discussions and events on the Vascular Forum, an open group for specialists accessed with mobile devices. RESULTS: From July 2015 to July 2017, 1013 subjects were discussed among 680 members. Twenty-six (2.57%) of these subjects were curiosities, 101 (9.97%) related to diagnostic doubts, 492 (48.57%) to treatment doubts, and 205 (20.24%) to general doubts, while 189 (17.5%) were case reports. The mean number of interactions per event was 16.599 (±1.366). The mean time from posting of a new subject to the first reply was 42.14 (±7.55) min. The subject discussed was miscellaneous in 358 cases, venous in 336 cases, lymphatic in 15 cases, and arterial in 304 cases and the total number of replies was 15985. CONCLUSIONS: Interaction between experts using instant messaging technology proved capable of raising subjects for discussion and eliciting management approaches quickly. The rate of resolution, defined as the time taken for the first correct answer to be posted, was also high. The Vascular Forum proved to be a tool of great clinical value for its participants, confirming the importance of collective intelligence in medicine.